Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
100%(2 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
completednot_applicable

Thulium vs. Hol:YAG Laser

NCT05808257
recruitingnot_applicable

Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)

NCT05240001
recruitingnot_applicable

Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones

NCT05598645
completednot_applicable

Trial Assessing Renal Damage During Ureteroscopy

NCT05350423

Clinical Trials (4)

Showing 4 of 4 trials
NCT05808257Not Applicable

Thulium vs. Hol:YAG Laser

Completed
NCT05240001Not Applicable

Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)

Recruiting
NCT05598645Not Applicable

Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones

Recruiting
NCT05350423Not Applicable

Trial Assessing Renal Damage During Ureteroscopy

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4